Endometriosis (EM) is a common and highly morbid chronic disease associated with menorrhagia, dysmenorrhea, and anemia for which therapeutic options are limited. While originally indicated only for uterine fibroids (UF), Uterine Artery Embolization (UAE) has been shown to be an effective treatment for patients with adenomyosis (AM). AM often occurs jointly with EM, which is currently considered a relative contraindication to UAE. The prevalence EM and dearth of data on its impact on clinical outcomes after UAE demands further exploration.
What's Your Reaction?






